Side Effects of Drugs Annual A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions was first published in 1977, and has been continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each annual provides clinicians and medical investigators with a reliable and critical survey of new data and trends in the area of adverse drug reactions and interactions, with an international team of specialists contributing their expertise each year.
Contributors
Preface
Special Reviews in SEDA 38
Table of Essays, Annuals 1–37
Abbreviations
ADRs, ADEs and SEDs: A Bird's Eye View
Chapter 1: Central Nervous System Stimulants and Drugs That Suppress Appetite
Chapter 2: Antidepressant Drugs
Chapter 3: Lithium
Chapter 4: Hypnotics and Sedatives
Chapter 5: Antipsychotic Drugs
Chapter 6: Antiepileptics
Chapter 7: Opioid Analgesics and Narcotic Antagonists
Chapter 8: Anti-Inflammatory and Antipyretic Analgesics and Drugs Used in Gout
Chapter 9: General Anaesthetics and Therapeutic Gases
Chapter 10: Local Anesthetics
Chapter 11: Neuromuscular Blocking Agents and Skeletal Muscle Relaxants
Chapter 12: Drugs That Affect Autonomic Functions or the Extrapyramidal System
Chapter 13: Dermatological Drugs, Topical Agents, and Cosmetics
Chapter 14: Antihistamines (H1 Receptor Antagonists)
Chapter 15: Drugs That Act on the Respiratory Tract
Chapter 16: Positive Inotropic Drugs and Drugs Used in Dysrhythmias
Chapter 17: Beta-Adrenoceptor Antagonists and Antianginal Drugs
Chapter 18: Antihypertensives
Chapter 19: Diuretics
Chapter 20: Metals
Chapter 21: Metal Antagonists
Chapter 22: Antiseptic Drugs and Disinfectants
Chapter 23: Beta-Lactams and Tetracyclines
Chapter 24: Miscellaneous Antibacterial Drugs
Chapter 25: Antifungal Drugs
Chapter 26: Antiprotozoal Drugs
Chapter 27: Antiviral Drugs
Chapter 28: Drugs Used in Tuberculosis and Leprosy
Chapter 29: Antihelminthic Drugs
Chapter 30: Vaccines
Chapter 31: Blood, Blood Components, Plasma, and Plasma Products
Chapter 32: Vitamins, Amino Acids, and Drugs and Formulations Used in Nutrition
Chapter 33: Drugs That Affect Blood Coagulation, Fibrinolysis and Hemostasis
Chapter 34: Gastrointestinal Drugs
Chapter 35: Drugs That Act on the Immune System: Cytokines and Monoclonal Antibodies
Chapter 36: Drugs That Act on the Immune System: Immunosuppressive and Immunostimulatory Drugs
Chapter 37: Corticotrophins, Corticosteroids, and Prostaglandins
Chapter 38: Sex Hormones and Related Compounds, Including Hormonal Contraceptives
Chapter 39: Thyroid hormones, Iodine and Iodides, and Antithyroid Drugs
Chapter 40: Insulin Other Hypoglycemic Drugs
Chapter 41: Miscellaneous Hormones
Chapter 42: Drugs That Affect Lipid Metabolism
Chapter 43: Cytostatic Agents—Tyrosine Kinase Inhibitors Utilized in the Treatment of Solid Malignancies
Chapter 44: Radiological Contrast Agents and Radiopharmaceuticals
Chapter 45: Drugs Used in Ocular Treatment
Chapter 46: Safety of Complementary and Alternative Medicine (CAM) Treatments and Practices
Chapter 47: Miscellaneous Drugs, Materials, Medical Devices and Techniques
Reviewers List
Index of Drugs
Index of Drug-Drug Interactions
Index of Adverse Effects and Adverse Reactions
- Provides a critical yearly survey of the new data and trends regarding the side effects of drugs
- Authored and reviewed by worldwide pioneers in the clinical and practice sciences
- Presents an essential clinical on the side effects of drugs for practitioners and healthcare professionals alike
Date de parution : 10-2016
Ouvrage de 604 p.
21.4x27.6 cm
Mots-clés :
Adverse reactions; Albumin; Alpha1-antitrypsin; Alzheimer's disease; Amfetamine; Amphetamines; Antianginal drugs; Anti-D immunoglobulin; Appetite suppressants; Armodafinil; Atomoxetine; Beta blockers; Beta-adrenoceptor antagonists; Bilastine; Blood substitutes; Blood transfusion; C1 esterase inhibitor concentrate; Caffeine; Calcium channel blockers; Cetirizine; Chlorphenamine; Coagulation proteins; Contrave; Cryoprecipitate; Dextrans; Diphenhydramine; Donepezil; Doxylamine; Ebastine hydroxyzine; Epoetin; Erythrocytes; Erythropoietin; Etherified starches; Factor I; Factor II; Factor IX; Factor VIIa; Factor VIII; Fresh frozen plasma; Galantamine; Gelatin; Globulins; Granulocytes; Hemoglobin-based oxygen carriers; Immunoglobulins; Intravenous immunoglobulin; Ketotifen; Levocetirizine; Lisdexamfetamine; Lorcaserin; Metamfetamine; Methylphenidate; Methylxanthines; Modafinil; Nicorandil; Nitrates; Nitroglycerin; Oxatomide; Pharmacogenomics; Phentermine; Plasma products; Plasma substitutes; Platelets; Promethazine; Prothrombin complex concentrate; Qsymia; Ranolazine; Rivastigmine; Rupatadine; Side effects; Stem cells; Subcutaneous immunoglobulin; Thrombopoietin and receptor agonists; Treatment-emergent adverse effects; von Willebrand factor
